Nintedanib (BIBF 1120) prevents TGF-β-induced pro-fibrotic effects in primary human lung myofibroblasts derived from patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Hostettler, Katrin
Papakonstantinou, Eleni
Zhong, Jun
Karakiulakis, George
Lardinois, Didier
Tamm, Michael
Roth, Michael
机构
关键词
Idiopathic pulmonary fibrosis;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 30 条
  • [1] Anti-fibrotic effects of nintedanib (BIBF 1120) in primary human lung fibroblasts derived from idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Karakiulakis, George
    Tamm, Michael
    Lardinois, Didier
    Roth, Michael
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Anti-Fibrotic Effects Of Nintedanib (bibf 1120) In Primary Human Lung Fibroblasts Derived From Patients With Idiopathic Pulmonary Fibrosis And From Non-Fibrotic Controls
    Hostettler, K. E.
    Papakonstantinou, E.
    Klagas, J.
    Karakiulakis, G.
    Zhong, J.
    Tamm, M.
    Lardinois, D.
    Roth, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [3] Effect of pirfenidone on TGF-β-induced profibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Zhong, Jun
    Tamm, Michael
    Lardinois, Didier
    Roth, Michael
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    [J]. RESPIRATORY RESEARCH, 2014, 15
  • [5] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Katrin E Hostettler
    Jun Zhong
    Eleni Papakonstantinou
    George Karakiulakis
    Michael Tamm
    Petra Seidel
    Qingzhu Sun
    Jyotshna Mandal
    Didier Lardinois
    Christopher Lambers
    Michael Roth
    [J]. Respiratory Research, 15
  • [6] MTOR REGULATES TGF-β INDUCED PRO-FIBROTIC GENE EXPRESSION IN PRIMARY HUMAN LUNG FIBROBLASTS
    Woodcock, H. V.
    Eley, J. D.
    Nanthakumar, C.
    Maher, T. M.
    Mercer, P. F.
    Chambers, R. C.
    [J]. THORAX, 2016, 71 : A31 - A31
  • [7] Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis
    Kurumiya, Eon
    Iwata, Mayuu
    Kasuya, Yoshitoshi
    Tatsumi, Koichiro
    Honda, Takuya
    Murayama, Toshihiko
    Nakamura, Hiroyuki
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 966
  • [8] In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
    Escarrer-Garau, Gabriel
    Martin-Medina, Aina
    Truyols-Vives, Joan
    Gomez-Bellvert, Cristina
    Elowsson, Linda
    Westergren-Thorsson, Gunilla
    Molina-Molina, Maria
    Mercader-Barcelo, Josep
    Sala-Llinas, Ernest
    [J]. CELLS, 2024, 13 (02)
  • [9] Rapamycin Insensitive Mtor Signalling Promotes Tgf-β Induced Pro-Fibrotic Gene Expression In Human Lung Fibroblasts
    Woodcock, H.
    Eley, J.
    Peace, S.
    Nanthakumar, C.
    Maher, T. M.
    Mercer, P.
    Chambers, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Sun, Qingzhu
    Tamm, Michael
    Lambers, Christopher
    Roth, Michael
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46